Home Newsletters Immunology of Infectious Disease News Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in...

Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living with HIV: A Phase 1, Dose-Escalation Trial

0
Investigators administered a recombinant bicistronic adeno-associated virus (AAV8) vector coding for both the light and heavy chains of the potent broadly neutralizing HIV-1 antibody VRC07 to eight adults living with HIV.
[Nature Medicine]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version